The Mumbai bench of the National Company Law Tribunal (NCLT) has approved Casper Pharma’s merger with listed drug maker, Suven Pharmaceuticals. In April 2022, Suven Pharmaceuticals acquired Casper Pharma (CPPL) for...
Strides Pharma Global, Singapore to acquire balance 30% stake in Strides Switzerland
Strides Pharma Global, Singapore (SPG), a wholly owned step-down subsidiary of Strides Pharma Science, is acquiring a balance stake in Strides Pharma International AG (formerly Fairmed Healthcare AG) (Strides...
Mankind Pharma completes Rs 13,768 cr BSV acquisition
Mankind Pharma on Wednesday said it has completed the transaction to acquire Bharat Serums and Vaccines Ltd (BSV), for a consideration of Rs 13,768 crore. This strategic move marks a significant leap for the company...
EMS bids for rival Hypera to create Brazil’s largest drugmaker
Brazilian pharmaceutical company EMS has offered to join forces with rival Hypera to create the country’s biggest drug manufacturer, they said on Monday. In a securities filing, Hypera said its board will assess...
Quadria, TPG eye up to 25% stake for $100 mn in Samarth Life Sciences
Private equity investors including Quadria Capital and TPG Capital have expressed initial interest to invest about $100 million for a 20-25% stake in critical care drugs provider Samarth Life Sciences, three people...
Cipla, Alkem Laboratories in final lap to buy SMT
Drugmakers Cipla and Alkem Laboratories have emerged as the frontrunners to acquire a controlling stake in Sahajanand Medical Technologies (SMT), India’s largest cardiac stent maker, said people in the know. This...
France considering stake in Sanofi’s Opella, minister says
France is considering taking a stake in Sanofi’s Opella arm, said finance minister Antoine Armand, to allay concerns that the French drugmaker’s plans to sell a 50% stake in Opella to a U.S. private equity...
Vanda Pharmaceuticals rejects Cycle Pharma’s second takeover offer
Vanda Pharmaceuticals on Monday rejected UK-based Cycle Pharmaceuticals’ second takeover proposal, which values the drugmaker at $8 per share despite a drop in Vanda’s stock following the FDA’s...
PE firms queue up for Novartis’ Indian arm
Private equity firms ChrysCapital, Apollo Global Management, Kedaara Capital and Multiples Equity are evaluating the acquisition of Novartis AG’s 70.68% stake in its India-listed arm, according to the people with...
CCI clears Rs 13,630 cr Mankind Pharma acquisition of Bharat Serums
The Competition Commission of India (CCI) has cleared Mankind Pharma’s acquisition of Bharat Serums and Vaccines in a ₹13,630-crore deal. In a statement on Wednesday, the regulator said: “The proposed...
CCI clears Rs 13,630-cr Mankind Pharma-Bharat Serums Vaccines deal
The Competition Commission of India (CCI) on Tuesday approved the proposed acquisition of Bharat Serums and Vaccines by Mankind Pharma for Rs 13,630 crore. Listed firm Mankind Pharma is engaged in developing...
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.6%...
